RPG Life Science to modernize its bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 20 million. The project also involves expanding the present production capacity of Bulk Drugs from 83.3 kg/ month (1.0 TPA) to 150.0 kg/m (1.8 MTA) as per the following details-
S.No. | Name of the product | Existing | Proposed | Total |
1 | 64.2 | 31.8 | 96.0 | |
2 | Mycophenolate Mofetil | 42.5 | 47.5 | 90.0 |
3 | Daunomycin Hydrochloride | 33.3 | Nil | 33.0 |
4 | Daxorubicin Hydrochloride | 20.0 | Nil | 20.0 |
5 | Epirubicin Hydrochloride | 6.0 | Nil | 6.0 |
6 | Lovastatin | 70.8 | Nil | 70.8 |
7 | Pravastatine | 69.0 | Nil | 69.0 |
8 | Orlistat | 49.5 | Nil | 49.5 |
9 | Hyluronic Acid | Nil | 52.8 | 52.8 |
10 | Methyl Cobalamine | Nil | 25.0 | 25.0 |
11 | Idarubicin | Nil | 6.0 | 6.0 |
12 | Pirarubicin | Nil | 6.0 | 6.0 |
13 | Tachrolimus | Nil | 108.0 | 108.0 |
14 | Sirolimus (Rapamycin) | Nil | 108.0 | 108.0 |
15 | 11-Alpha hydroxy Canrenon | Nil | 134.4 | 134.0 |
| Total | 83.3 | 66.7 | 150.0 |
11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy